3D Global Biotech Inc. (TPEX:6808)

Taiwan · Delayed Price · Currency is TWD

40.75

+0.75 (1.88%)

Jul 21, 2026, 1:51 PM CST

-19.31% (1Y)

Market Cap	3.08B -21.7%
Revenue (ttm)	206.74M -22.2%
Net Income	66.53M -27.5%
EPS	0.84 -35.4%
Shares Out	76.98M
PE Ratio	47.62
Forward PE	n/a
Dividend	0.10 (0.25%)
Ex-Dividend Date	Jul 16, 2026

Volume	563,808
Open	40.50
Previous Close	40.00
Day's Range	38.00 - 40.95
52-Week Range	22.45 - 63.00
Beta	0.21
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About 3D Global Biotech

3D Global Biotech Inc. manufactures and sells medical devices for human body reconstruction. It offers artificial bone grafting; 3D bioForming; bio-dressing; 3D bioture EX; 3D printing equipment, such as 3D BioRealizer system; orthodontic aligner system under the SmileAlign name; and iMatrix, a sectional matrix kit. The company was founded in 2014 and is based in New Taipei City, Taiwan. [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2014

Employees 43

Stock Exchange Taipei Exchange

Ticker Symbol 6808

Full Company Profile

Financial Performance

In 2025, 3D Global Biotech's revenue was 206.74 million, a decrease of -22.19% compared to the previous year's 265.69 million. Earnings were 66.53 million, a decrease of -27.45%.

Financial Statements